Natalie Rath

553 total citations
18 papers, 402 citations indexed

About

Natalie Rath is a scholar working on Surgery, Gastroenterology and Genetics. According to data from OpenAlex, Natalie Rath has authored 18 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 9 papers in Gastroenterology and 5 papers in Genetics. Recurrent topics in Natalie Rath's work include Gastroesophageal reflux and treatments (9 papers), Helicobacter pylori-related gastroenterology studies (6 papers) and Inflammatory Bowel Disease (5 papers). Natalie Rath is often cited by papers focused on Gastroesophageal reflux and treatments (9 papers), Helicobacter pylori-related gastroenterology studies (6 papers) and Inflammatory Bowel Disease (5 papers). Natalie Rath collaborates with scholars based in United States, Poland and Italy. Natalie Rath's co-authors include Gail M. Comer, Mary K. Maguire, Silvio Danese, Meng Xu, Robert M. Ward, Anna Kohn, Gerhard Rogler, Gerald Fraser, Rupert W. Leong and Remo Panaccione and has published in prestigious journals such as Gastroenterology, Gut and The American Journal of Gastroenterology.

In The Last Decade

Natalie Rath

18 papers receiving 393 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Natalie Rath United States	10	131	124	117	107	72	18	402
Piotr Radwan Poland	10	116 0.9×	65 0.5×	47 0.4×	236 2.2×	88 1.2×	32	471
Riko Ichikawa Japan	7	88 0.7×	155 1.3×	81 0.7×	52 0.5×	97 1.3×	7	434
Lamia Kallel Tunisia	13	213 1.6×	187 1.5×	102 0.9×	75 0.7×	208 2.9×	49	478
Oldřich Pozler Czechia	11	72 0.5×	163 1.3×	110 0.9×	60 0.6×	72 1.0×	19	335
Nicolas Ferrari France	6	269 2.1×	60 0.5×	15 0.1×	42 0.4×	110 1.5×	10	630
Norman Händel Germany	8	57 0.4×	106 0.9×	119 1.0×	51 0.5×	139 1.9×	11	343
Sharon O’Byrne United Kingdom	10	325 2.5×	103 0.8×	28 0.2×	170 1.6×	196 2.7×	27	498
Ruth de Francisco Spain	10	160 1.2×	101 0.8×	40 0.3×	28 0.3×	148 2.1×	29	303
Stefano Festa Italy	9	102 0.8×	122 1.0×	59 0.5×	16 0.1×	160 2.2×	29	362
Di Mario F Italy	11	34 0.3×	217 1.8×	112 1.0×	25 0.2×	81 1.1×	38	374

Countries citing papers authored by Natalie Rath

Since Specialization

Citations

This map shows the geographic impact of Natalie Rath's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Natalie Rath with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Natalie Rath more than expected).

Fields of papers citing papers by Natalie Rath

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Natalie Rath. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Natalie Rath. The network helps show where Natalie Rath may publish in the future.

Co-authorship network of co-authors of Natalie Rath

This figure shows the co-authorship network connecting the top 25 collaborators of Natalie Rath. A scholar is included among the top collaborators of Natalie Rath based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Natalie Rath. Natalie Rath is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Danese, Silvio, Maria Kłopocka, Ellen Scherl, et al.. (2021). Anti-TL1A Antibody PF-06480605 Safety and Efficacy for Ulcerative Colitis: A Phase 2a Single-Arm Study. Clinical Gastroenterology and Hepatology. 19(11). 2324–2332.e6. 60 indexed citations

Neelakantan, Srividya, Barry S. Oemar, Natalie Rath, et al.. (2020). Safety, Tolerability, and Pharmacokinetics of PF‐06823859, an Anti–Interferon β Monoclonal Antibody: A Randomized, Phase I, Single‐ and Multiple‐Ascending‐Dose Study. Clinical Pharmacology in Drug Development. 10(3). 307–316. 10 indexed citations

Danese, Silvio, Maria Kłopocka, Ellen Scherl, et al.. (2020). 1027 SAFETY, TOLERABILITY, AND EFFICACY OF ANTI-TL1A ANTIBODY PF-06480605 IN TREATMENT OF ULCERATIVE COLITIS: THE OPEN-LABEL, MULTICENTER, PHASE 2A TUSCANY STUDY. Gastroenterology. 158(6). S–206. 1 indexed citations

Danese, Silvio, Séverine Vermeire, Paul Hellstern, et al.. (2017). Randomised trial and open-label extension study of an anti-interleukin-6 antibody in Crohn’s disease (ANDANTE I and II). Gut. 68(1). 40–48. 136 indexed citations

Danese, Silvio, Séverine Vermeire, Peter Hellstern, et al.. (2016). Results of ANDANTE, a randomised clinical study with an anti-IL6 antibody (PF-04236921) in subjects with Crohn's disease who are antitumour necrosis factor inadequate responders. 6 indexed citations

Danese, Silvio, Séverine Vermeire, Paul Hellstern, et al.. (2016). 764 Results of Andante, a Randomized Clinical Study With an Anti-IL6 Antibody (PF-04236921) in Subjects With Crohn's Disease Who Are Anti-TNF Inadequate Responders. Gastroenterology. 150(4). S155–S155. 4 indexed citations

Sullivan, Janice E., Kim G. Adcock, Jarosław Kierkuś, et al.. (2011). Randomized, Open-Label, Multicentre Pharmacokinetic Studies of Two Dose Levels of Pantoprazole Granules in Infants and Children Aged 1 Month through <6 Years with Gastro-Oesophageal Reflux Disease. Clinical Pharmacokinetics. 50(8). 541–550. 14 indexed citations

Kierkuś, Jarosław, Wanda Furmaga-Jabłońska, Janice E. Sullivan, et al.. (2010). Pharmacodynamics and Safety of Pantoprazole in Neonates, Preterm Infants, and Infants Aged 1 Through 11 Months with a Clinical Diagnosis of Gastroesophageal Reflux Disease. Digestive Diseases and Sciences. 56(2). 425–434. 21 indexed citations

Ward, Robert M., Gregory L. Kearns, Molly O’Gorman, et al.. (2010). A Multicenter, Randomized, Open-Label, Pharmacokinetics and Safety Study of Pantoprazole Tablets in Children and Adolescents Aged 6 Through 16 Years With Gastroesophageal Reflux Disease. The Journal of Clinical Pharmacology. 51(6). 876–887. 26 indexed citations

10.

Baker, Robert D., Susan S. Baker, Hui‐Hua Li, et al.. (2010). Clinical Results From a Randomized, Double-Blind, Dose-Ranging Study of Pantoprazole in Children Aged 1 Through 5 Years With Symptomatic Histologic or Erosive Esophagitis. Clinical Pediatrics. 49(9). 852–865. 20 indexed citations

11.

Ward, Robert M., Sandra Sullivan, Dan L. Stewart, et al.. (2010). Single-dose, multiple-dose, and population pharmacokinetics of pantoprazole in neonates and preterm infants with a clinical diagnosis of gastroesophageal reflux disease (GERD). European Journal of Clinical Pharmacology. 66(6). 555–561. 50 indexed citations

12.

Comer, Gail M., Robert D. Baker, Hui‐Hua Li, et al.. (2009). M1909 Randomized, Double-Blind Clinical Outcomes, Safety, and Tolerability Study of Pantoprazole Delayed-Release Granules in Children Aged 1 to 5 Years with Endoscopically Proven Symptomatic Gastroesophageal Reflux Disease (GERD). Gastroenterology. 136(5). A–444. 4 indexed citations

13.

Comer, Gail M., Jarosław Kierkuś, Janice E. Sullivan, et al.. (2009). M1908 Pharmacodynamics (PD) and Safety of Pantoprazole Delayed-Release Granules in Infants Aged 1 Through 11 Months with a Clinical Diagnosis of Gastroesophageal Reflux Disease (GERD). Gastroenterology. 136(5). A–443. 2 indexed citations

14.

Kierkuś, Jarosław, Natalie Rath, Caifeng Fu, et al.. (2008). Pharmacokinetics of Two Dose Levels of Pantoprazole Sodium Delayed-Release Granules for Oral Suspension in Infants Aged 1 Through 11 Months with a Presumed Diagnosis of GERD. The American Journal of Gastroenterology. 103. S527–S528. 3 indexed citations

15.

Hogan, Daniel L., Dennis Riff, Hillel T. Schwartz, et al.. (2007). Oral pantoprazole in the form of granules or tablets are pharmacodynamically equivalent in suppressing acid output in patients with gastro‐oesophageal reflux disease and a history of erosive oesophagitis. Alimentary Pharmacology & Therapeutics. 26(2). 249–256. 6 indexed citations

16.

Rath, Natalie & H K Kar. (2004). Leprosy in HIV infection: a study of three cases.. PubMed. 75(4). 355–9. 4 indexed citations

17.

Rath, Natalie, et al.. (1988). Methotrexate suppresses passive adjuvant arthritis: studies on the metabolism of methotrexate in mononuclear cells derived from normal and adjuvant arthritic rats.. PubMed. 15(8). 1193–7. 13 indexed citations

18.

Rath, Natalie, et al.. (1986). Studies on the effect of D-penicillamine, gold thioglucose and methotrexate on streptococcal cell wall arthritis.. PubMed. 13(5). 895–8. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact